Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ATP7A Transporter as Biomarker for Predicting Chemoresistance of Serous Ovarian Cancer

NCT05490407 is registered in ClinicalTrials.gov with University Medical Centre Ljubljana as lead sponsor.

NCT NCT05490407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05490407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ATP7A Transporter as Biomarker for Predicting Chemoresistance of Serous Ovarian Cancer
Lead sponsor
University Medical Centre Ljubljana
Phase
Not applicable
Overall status
Completed
Start date
March 17, 2021
Completion date
January 1, 2024
Enrollment
40 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy effect, gynecologic cancer, high grade serous carcinoma, ovarian cancer